ReiThera
Rome, IT
1 confirmed programs
· 1 sponsors
· Last scored 2026-10-29
71.1
Signal Score
○ FDA Inspections
✓ Clinical Trials (1)
○ SEC Filings
○ Press
✓ EMA GMP (4)
○ MHRA GMP
Quick Facts: ReiThera
- Signal Score
- 71.1/100 (as of 2026-10-29)
- Quality Compliance
- 100.0/100 — Clean EMA record: 4 active GMP certificates (no deductions)
- Headquarters
- Rome, IT
- Modalities
- Adenoviral, AAV
- Active Programs
- 1 confirmed from ClinicalTrials.gov across 1 sponsors
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About ReiThera
Italian viral vector CDMO. COVID vaccine development.
Signal Score & Pillar Breakdown
Quality Compliance
100.0
Clean EMA record: 4 active GMP certificates (no deductions)
Sources: FDA Data Dashboard, EMA EudraGMDP
Clean EMA record: 4 active GMP certificates (no deductions)
FDA InspectionsNo US records on file
EMA GMP Certificates4 on record
Clean EMA record: 4 active GMP certificates (no deductions)
Operations
50.0
1 active programs across 1 sponsors
Modalities: Adenoviral, AAV
Source: ClinicalTrials.gov
1 active programs across 1 sponsors · Modalities: Adenoviral, AAV
Programs
1
Sponsors1
ModalitiesAdenoviral, AAV
1 active programs across 1 sponsors
Modalities: Adenoviral, AAV
Source: ClinicalTrials.gov facility matching
Source: ClinicalTrials.gov · Retrieved Nov 21, 2026
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
58.0
1 manufacturing site: Rome, Italy
Modalities: Adenoviral, AAV
Capacity assessment: 58.0/100
Sites: Rome, Italy
Source: company profiles (manufacturing sites, modality breadth)
1 manufacturing site
1 manufacturing site: Rome, Italy
Modalities: Adenoviral, AAV
Capacity assessment: 58.0/100
ReiThera EMA GMP Compliance 4 certificates
2024-11
2024-11
2022-01
2022-01
Compliant
Non-Compliant
| Certificate | Site | Country | Inspection Date | Status |
|---|---|---|---|---|
| IT/44/H/2025 | Reithera S.r.l. | Italy | 2024-11-22 | COMPLIANT |
| IT-API/32/H/2025 | Reithera S.r.l. | Italy | 2024-11-22 | COMPLIANT |
| IT-API/119/H/2022 | Reithera S.r.l. | Italy | 2022-01-28 | COMPLIANT |
| IT-API/251/H/2022 | Reithera S.r.l. | Italy | 2022-01-28 | COMPLIANT |
Source: EMA EudraGMDP · Retrieved Nov 21, 2026
Clinical Activity 1 studies
Source: ClinicalTrials.gov · Retrieved Nov 21, 2026
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Nov 20, 2026
Frequently Asked Questions About ReiThera
Does ReiThera hold EMA or MHRA GMP certificates?
CDMO Signal tracks 4 EMA GMP certificates for ReiThera.
How many clinical programs is ReiThera linked to?
ReiThera is associated with 1 clinical trial in CDMO Signal's ClinicalTrials.gov-sourced data.
What is ReiThera's CDMO Signal Score?
ReiThera has a Signal Score of 71/100, based on quality, operations, financial stability, and capacity data.
Evaluating ReiThera for a manufacturing program?
Use the free AI matchmaker to compare ReiThera against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
SK pharmteco
Dublin, Ireland. Rancho Cordova, CA. King of Prussia, PA. Houston, TX. Korea. France.
Signal Score: 79.5
Viral Vectors, AAV, Lentiviral, Adenoviral, HPAPIs, Small Molecules, Peptides, BioCatalysis, Chromatography, Cell Therapy
Exothera
Jumet, BE
Signal Score: 78.1
AAV, Adenoviral, Lentiviral
Advent Bioservices
London, United Kingdom
Signal Score: 78.1
AAV, Lentiviral, Adenoviral
Thermo Fisher Scientific
Plainville, MA · Alachua, FL · Cambridge, MA
Signal Score: 77.6
AAV, Lentiviral, Plasmid DNA, Adenoviral, Plasmid, Small Molecule API, Oral Solid Dose, Sterile Fill-Finish
Emergent BioSolutions (CGT)
Baltimore, MD
Signal Score: 66.1
AAV, Adenoviral
Compare ReiThera with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.